Continued approval for this indication may depend upon confirmation of clinical benefit in additional trials.
QALSODY is a type of therapy called an antisense oligonucleotide (ASO). ASOs are able to bind
directly to specific mRNA to change the amount of protein produced by the body.
Sign up to receive product information and
Please enter a valid email address.